EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.22.26 | Adenocarcinoma |
16269926 |
Cancer procoagulant in patients with adenocarcinomas. |
causal interaction diagnostic usage unassigned |
3 3 0 |
3.4.22.26 | Blood Coagulation Disorders |
16171148 |
[Cancer procoagulant (CP)] |
causal interaction diagnostic usage ongoing research therapeutic application |
3 2 2 2 |
3.4.22.26 | Breast Neoplasms |
10656610 |
Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients. |
diagnostic usage therapeutic application unassigned |
4 1 0 |
3.4.22.26 | Breast Neoplasms |
22718627 |
The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines. |
causal interaction diagnostic usage ongoing research unassigned |
4 3 4 0 |
3.4.22.26 | Carcinoma |
1310878 |
Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients. |
causal interaction diagnostic usage therapeutic application unassigned |
4 3 1 0 |
3.4.22.26 | Carcinoma |
2298496 |
Cancer procoagulant in serum of rats during development of experimental epithelioma. |
ongoing research unassigned |
4 0 |
3.4.22.26 | Carcinoma |
2501168 |
Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma. |
therapeutic application unassigned |
1 0 |
3.4.22.26 | Carcinoma |
3294610 |
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics. |
causal interaction ongoing research therapeutic application unassigned |
1 4 1 0 |
3.4.22.26 | Carcinoma |
3530904 |
gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant. |
causal interaction therapeutic application unassigned |
3 1 0 |
3.4.22.26 | Carcinoma |
3933592 |
Cysteine proteinase procoagulant from amnion-chorion. |
causal interaction diagnostic usage ongoing research unassigned |
3 1 3 0 |